/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Martin Blunck

Bayer (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

10

Papers

188

Citations

6

h-index

2

i10-index

Martin Blunck is an academic researcher from Bayer (United States). The author has contributed to research in topics: Heart Failure Treatment and Management & Phosphodiesterase function and regulation & Biotechnology and Related Fields. The author has an h-index of 6, co-authored 9 publications.

Research Topics

Heart Failure Treatment and Management Phosphodiesterase function and regulation Biotechnology and Related Fields Antifungal resistance and susceptibility Microbial Natural Products and Biosynthesis

Papers by this author

works

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

2014 · Clinical Pharmacology Advances and Applications · 126 citations

https://doi.org/10.2147/cpaa.s47895

Johannes Nagelschmitz Martin Blunck Joern Kraetzschmar Matthias Ludwig

Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls

2011 · BMC Pharmacology · 0 citations

https://doi.org/10.1186/1471-2210-11-s1-p61

Christian Scheerans Martin Blunck Wolfgang Mueck Reiner Frey

Research topics

topics

Heart Failure Treatment and Management

Phosphodiesterase function and regulation

Biotechnology and Related Fields

Antifungal resistance and susceptibility

Microbial Natural Products and Biosynthesis

Chat about Author

Papers

Chat

Click to start Chat